NDC 67871-773-35 - Nascobal
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 67871-773
- Requested NDC
- 67871-773-35
- Package NDCs from labels
- 67871-773-35
- Manufacturer
- QOL Medical, LLC
- Effective date
- 2006-09-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nascobal - QOL Medical, LLC | QOL Medical, LLC | 2006-09-15 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67871-773-35 | Nascobal | 8 in 1 BOTTLE | SPRAY | 8 | 1 | |
| 67871-773-35 | Nascobal | 1 in 1 CARTON | SPRAY | 1 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | NASCOBAL (CYANOCOBALAMIN) SPRAY [QOL MEDICAL, LLC] | 1 | |
| cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | NASCOBAL (CYANOCOBALAMIN) SPRAY [QOL MEDICAL, LLC] | 1 | |
| benzalkonium chloride | INACTIVE INGREDIENT | NASCOBAL (CYANOCOBALAMIN) SPRAY [QOL MEDICAL, LLC] | 1 | ||
| citric acid | INACTIVE INGREDIENT | 2968PHW8QP | NASCOBAL (CYANOCOBALAMIN) SPRAY [QOL MEDICAL, LLC] | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | NASCOBAL (CYANOCOBALAMIN) SPRAY [QOL MEDICAL, LLC] | 1 | |
| sodium citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | NASCOBAL (CYANOCOBALAMIN) SPRAY [QOL MEDICAL, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nascobal | CYANOCOBALAMIN | Par Health USA, LLC | 697e0e52-c01b-4b53-9994-f79c46eb6b4f | 2024-03-01 | Warnings, Adverse reactions | 861115 861113 |
| Cyanocobalamin | CYANOCOBALAMIN | Lupin Pharmaceuticals,Inc. | efb7dc02-f0c9-4537-9e23-b641c428068c | 2023-08-24 | Warnings, Adverse reactions | 861113 |
| cyanocobalamin | CYANOCOBALAMIN | Padagis Israel Pharmaceuticals Ltd | 971e5f30-55c2-4193-9dd8-b43a1862b92a | 2023-02-28 | Warnings, Adverse reactions | 861113 |
| 75178615-4CB2-1B90-FAE8-832236072318 | EE2B4869-CD13-489B-B12F-1CE4FE081157 | 2006-09-15 | Warnings, Adverse reactions | 75178615-4CB2-1B90-FAE8-832236072318 EE2B4869-CD13-489B-B12F-1CE4FE081157 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.